Atopic dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 7, Issue 2, 1996, Pages 101-114

  Bos, J D ^a   Sillevis Smitt, J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atopic eczema; Immunology; Pathogenesis; Therapy

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; ASCOMYCIN; CORTICOSTEROID; CYCLOSPORIN; DOXEPIN; ERYTHROMYCIN; FLUCLOXACILLIN; HYDROCORTISONE ACETATE; KETOCONAZOLE; KETOTIFEN; METHOXSALEN; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS; TAR; TRIAMCINOLONE ACETONIDE; ZINC OXIDE;

ATOPIC DERMATITIS; DRUG THERAPY; HERBAL MEDICINE; HUMAN; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET A RADIATION;

EID: 0029740992     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0926-9959(96)00079-7     Document Type: Article

References (94)

1. Besnier E. Première note et observations préliminaires pour servir d'introduction à l'étude des prurigos diasthésiques. Ann Dermatol Syph 1892;23:634.
2. Rystedt I. Hand eczema and long-term prognosis in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985;117.
3. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-47.
4. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
5. Björksten B, Kjellmann NIM. Perinatal factors influencing the development of allergy. Clin Rev Allergy 1987;5:339-347.
6. Larsen FS. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719.
7. Cookson WOCM, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;i:1292-1295.
8. Young RP, Sharp PA, Lynch JR et al. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992;29:236-238.
9. Sandford AJ, Shirakawa T, Moffatt MF, Daniels SE, Ra C, Faux JA, Young RP, Nakamuura Y, Lathrop GM, Cookson WOCM, Hopkin JM. Localization of atopy and β subunit of high-affinity IgE receptor (FceR1) on chromosome 11q. Lancet 1993;341:332-334.
10. Coleman R, Trembath RC, Harper JI. Chromosome 11q13 and atopy underlying atopic eczema. Lancet 1993;341:1121-1122.
11. Marsh DG, Neely JD, Breazeale DR, Ghoah B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-1156.
12. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CIM, Meyers DA, Levitt RC. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. New Engl J Med 1995;333:894-900.
13. Burton JL. Dietary fatty acids and inflammatory skin disease. Lancet 1989;i:27-31.
14. 1? J Am Acad Dermatol 1989;23:557-563.
15. Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol 1966;97:75-85.
16. Pène J, Rousset F, Brière F, Chrétien I, Bonnefoy JY, Spits H, Yokota T, Arai N, Banchereau J, De Vries JE. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2. Proc Natl Acad Sci USA 1988;85:6880-6884.
17. + T lymphocytes in atopic patients. J Immunol 1990;144:4651-4656.
18. Wierenga EA, Snoek M, Jansen HM, Bos JD, Van Lier RAW, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-2949.
19. + T-cells. Immunol Today 1991;12:392-395.
20. Fargeas C, Wu CY, Nakajima T, Cox D, Nutman T, Delespesse G. Differential effect of transforming growth factor β on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur J Immunol 1992;22:2173-2176.
21. Manetti R, Parronchi P, Giudizi MG, Picinni MP, Maggi E, Trinchieri G, Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
22. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992;148;2142-2147.
23. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
24. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-5329.
25. Chan SC, Li S-H, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993;100:681-684.
26. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995;95:913-918.
27. Bos JD, Wierenga EA, Sillevis Smitt JH, Van der Heijden FL, Kapsenberg ML. Immune dysregulation in atopic eczema. Arch Dermatol 1992;128:1509-1512.
28. Bos JD, Kapsenberg ML, Sillevis Smitt JH. Pathogenesis of atopic eczema. Lancet 1994;343:1338-1341.
29. Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993;14:75-78.
30. Sillevis Smitt JH, Bos JD, Hulsebosch HJ, Krieg SR. In situ immunophenotyping of antigen presenting cells and T cell subsets in atopic dermatitis. Clin Exp Dermatol 1986;11:159-168.
31. + allergenspecific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
32. Ramb-Lindhauer C, Feldmann A, Rotte M, Neumann C. Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin. Arch Dermatol Res 1991;283:71-76.
33. Van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS. Skin-derived aeroallergen-specific T cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184-193.
34. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992;89:801-810.
35. Grewe M, Gyufko K, Schöpf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994;343:25-26.
36. Grewe M, Walther M, Gyufko K, Czech W, Schöpf E, Krutmann J. Analysis of the cytokine pattern expressed in situ inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105:407-410.
37. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-876.
38. Bruijnzeel-Koomen C, Van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986;278:199-205.
39. Bieber T, Ring J. In vivo modulation of the high-affinity receptor for IgE (FceRI) on human epidermal Langerhans cells, Int Arch Allergy Immunol 1992;99:204-207.
40. Maurer D, Stingl G. Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J Invest Dermatol 1995;104:707-710.
41. Mudde GC, Van Reijsen FC, Boland GJ, De Gast GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335-341.
42. Van der Heijden FL, Van Neerven RJJ, Van Katwijk M, Bos JD, Kapsenberg ML. Serum IgE-facilitated allergen presentation in atopic disease. J Immunol 1993;50:3643-3650.
43. Sillevis Smitt JH, Weening RS. Dermatological manifestations of congenital immunodeficiencies. In: Bos JD, ed. Skin Immune System (SIS). CRC Press, Boca Raton, FL, 1990:329-342.
44. Dooms-Goossens A, Meinardi MMHM, Bos JD, De Greef H. Contact allergy to corticosteroids: the results of a two-centre study. Br J Dermatol 1994;130:42-47.
45. Lepoittevin J-P, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Arch Dermatol 1995;131:31-37.
46. Ring J, Ruzicka T, Przybilla B, eds. Handbook of Atopic Eczema. Springer, Berlin, 1991:330-335.
47. Champion RH, Parish WE. Atopic dermatitis. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. Blackwell Scientific Publications, Oxford, 1992:589-610.
48. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-137.
49. Przybilla B, Eberlein-König B, Ruëff F. Practical management of atopic eczema. Lancet 1994;343:1342-1346.
50. Sillevis Smitt JH, Bos JD. Therapie van constitutioneel eczeem. Ned Tijdschr Dermatol Venereol 1995;5:213-216.
51. Snijdewint FGM, Kapsenberg ML, Wauben-Penris PJJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1-and Th2-type cytokine production. Immunopharmacology 1995;29:93-101.
52. Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Soe D, Nishima S. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992;68:233-236.
53. Chandra RK, Puri S, Hamed A. Influence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants. Br Med J 1989;299:228-230.
54. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow's milk and fish during lactation: effect on allergic manifestations, skin-prick tests and specific IgE antibodies in children at age 4 years. Pediatrics 1992;89:735-739.
55. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: an evaluation of 113 patients. J Pediatr 1985;107:669-675.
56. Van Gysel D, Bruynzeel DP, Dieges PH, Oranje AP. Directe en vertraagd type (contact) overgevoeligheid bij atopisch eczeem bij kinderen. Ned Tijdschr Dermatol Venereol 1994;4:134-136.
57. Vieluf D, Przybilla B, Traencker I, Ring J. Provocation of atopic eczema by oral challenge tests with food additives. J Allergy Clin Immunol 1990;85:206 (abst).
58. Przybilla B, Ring J. Food allergy and atopic eczema. Semin Dermatol 1990;9:220-225.
59. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance in atopic dermatitis. Lancet 1996;347:15-18.
60. Sillevis Smitt JH, Winterberg DH. Het lokale gebruik van corticosteroïden bij huidaandoeningen op de kinderleeftijd. Ned Tijdschr Geneeskd 1991;135:2156-2159.
61. Parkin JM. The short child. in: Brook CGD, ed. Clinical Paediatric Endocrinology. Blackwell Scientific Publications, Oxford, 1989:96-118.
62. Turpeinen M. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis. Eur J Pediatr 1989;148:729-731.
63. Weston WL, Mitchell Sams W, Morris HG, Arthur JM, Blakeman GJ, Andresen M. Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids. Pediatrics 1980;65:103-106.
64. Vickers CFH. Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 1963;88:72-75.
65. Franz TJ. Kinetics of cutaneous drug penetration. Int J Dermatol 1983;22:499-505.
66. Polano MK. Topical Skin Therapeutics. Churchill Livingstone, Edinburgh, 1984:132-134.
67. Meingassner JG, Stütz A. Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992;98:851-855.
68. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, Harada S. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:883.
69. Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK 506 ointment. Br J Dermatol 1995;133:494-496.
70. Atherton DJ, Carabott F, Glover MT, Hawk JLM. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol 1988;118:791-795.
71. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225-230.
72. Kowalzick L, Kleinheinz A, Weichenthal M, Neuber K, Köhler I, Grosch J, Lungwitz G, Seegeberg C, Ring J. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol (Stockh) 1995;75:43-45.
73. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrowband (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49-56.
74. Sonenthal KR, Grammer LC, Patterson R. Do some patients with atopic dermatitis require long-term oral steroid therapy? J Allergy Clin Immunol 1993;91:971-973.
75. Van Joost T, Stolz E, Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol 1987;123:166-167.
76. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown EA, Allen BR, Camp RD. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-140.
77. Sepp N, Fritsch PO. Can ciclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol 1993;128:213-216.
78. Munro CS, Levell NJ, Shuster S, Friedmann PS. Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 1994;130:376-380.
79. Jacquemin MG, Machiels JJ, Lebrun PM, Saint-Remy JMR. Successful treatment of atopic dermatitis with complexes of allergen and specific antibodies. Lancet 1990;335:1468-1469.
80. 2 fragments of specific antibodies. Br J Dermatol 1995;132:599-603.
81. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AZ, Bucalo LR, Hirabayashi SE, Tofte SJ, CantuGonzales G, Milgrom H, Boguniewicz, M, Cooper KD. Recombinant Interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-197.
82. Berth-Jones J, Graham-Brown RAC. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-1560.
83. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in wide-spread non-exsudative atopic eczema. Br J Dermatol 1992;126:483-488.
84. Sheehan MP, Rustin HMA, Atherton DJ et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13-17.
85. Sheehan MP, Stevens H, Osterle LS et al. Follow-up of adult patients with atopic eczema treated with Chinese herbal theapy for 1 year. Clin Exp Dermatol 1995;20:136-140.
86. Drake LA, Millikan LE, Doxepin Study Group. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Arch Dermatol 1995;131:1403-1408.
87. Wahlgren CF, Hägermark Ö, Bergström R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990;122:545.
88. Wahlgren CF. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992;47:65-75.
89. Hauser C, Wuetrich B, Matter L, Wilhelm JA, Sonnabend W, Schöpfer K. Staphylococcus aureus colonization in atopic dermatitis patients. Dermatologica 1985;170:35-39.
90. David TJ, Cambridge GC. Bacterial infection and atopic eczema. Arch Dis Childh 1986;61:20-23.
91. Leung DYM, Harbeck R, Bina P, Reiser RF, Yand E, Norris DA, Hanifin JM, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 1993;92:1374-1380.
92. Bork K, Bräuninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024-1029.
93. Jensen-Jarolim E, Poulsen LK, With H, Kieffer M, Ottevanger V, Stahl Skov P. Atopic dermatitis of the face, scalp, and neck: Type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol 1992;89:44-51.
94. Bäck O, Scheynius A, Johansson SGO. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.